China · Delayed Price · Currency is CNY Shanghai Rightongene Biotechnology Company Description
Shanghai Rightongene Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products.
The company provides gene and antigen testing for patients; and offers treatment plans, such as disease diagnosis, risk assessment, disease classification, targeted drug selection, and efficacy monitoring for for initial screening, follow-up, and re-examination of leukemia patients.
It also offers molecular diagnostic kits for genes related to leukemia, lymphoma, solid tumors, and infectious diseases.
In addition, it provides third-party medical testing services to various medical institutions, pharmaceutical companies, and individual patients, as well as gene testing research services to research hospitals, pharmaceutical companies, research institutions, and other third-party testing organizations.
Shanghai Rightongene Biotechnology Co., Ltd. was founded in 2012 and is based in Shanghai, China.
| Country | China |
| Founded | 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 336 |
| CEO | Shangxian Gao |
Contact Details
Address: No. 147, Lane 1817 Shanghai, 201403 China | |
| Phone | 86 21 3328 2601 |
| Website | rightongene.com |
Stock Details
| Ticker Symbol | 688217 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Shangxian Gao | Acting Chairman and GM |
| Hui Xiong | Chairman and GM |
| Chengli Zhang | Deputy General Manager |
| Liqun Xie | Deputy General Manager |
| Zhong He Ke | R&D Director and Director |